{"id":42376,"date":"2022-03-01T07:15:07","date_gmt":"2022-03-01T07:15:07","guid":{"rendered":"https:\/\/i-base.info\/htb\/?p=42376"},"modified":"2022-03-01T11:56:10","modified_gmt":"2022-03-01T11:56:10","slug":"major-review-finds-little-benefit-of-remdesivir-in-people-hospitalised-with-covid-19","status":"publish","type":"post","link":"https:\/\/i-base.info\/htb\/42376","title":{"rendered":"Major review finds little benefit of remdesivir in people hospitalised with COVID-19"},"content":{"rendered":"<div><\/div>\n<div>\n<p class=\"HTBsubhead3authorcredit\"><strong><span lang=\"EN-US\">Simon Collins, HIV i-Base<\/span><\/strong><\/p>\n<\/div>\n<div>\n<p class=\"HTBsubhead3authorcredit\"><strong><span lang=\"EN-US\"><img loading=\"lazy\" decoding=\"async\" class=\" alignright\" src=\"https:\/\/i-base.info\/wp-content\/uploads\/2020\/03\/COVID-19-graphic.png\" width=\"231\" height=\"142\" \/>A final update to this ongoing review of randomised controlled trials using remdesivir concludes that <\/span>In hospitalised adults with COVID-19, remdesivir probably results in little to no difference in mortality. <\/strong><\/p>\n<p class=\"HTBsubhead3authorcredit\">Although remdesivir may reduce time to clinical improvement and may lead to small reductions in serious adverse events it may also results in a small increase in any adverse event.<\/p>\n<\/div>\n<div>\n<p class=\"HTBBODYFIRST\"><span lang=\"EN-US\">Reference<\/span><\/p>\n<\/div>\n<div>\n<p class=\"HTBBODYtext\"><span lang=\"EN-US\">Kaka AS et al. Major update 2: remdesivir for adults with COVID-19: A living systematic review and meta-analysis for the American College of Physicians. Ann Intern Med. [Epub ahead of print 1 March 2022]. doi:10.7326\/M21-4784.<br \/>\n<\/span><a href=\"https:\/\/www.acpjournals.org\/doi\/10.7326\/M21-4784\">https:\/\/www.acpjournals.org\/doi\/10.7326\/M21-4784<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Simon Collins, HIV i-Base A final update to this ongoing review of randomised controlled trials using remdesivir concludes that In hospitalised adults with COVID-19, remdesivir probably results in little to no difference in mortality. Although remdesivir may reduce time to &hellip;<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[283,278],"tags":[],"class_list":["post-42376","post","type-post","status-publish","format-standard","hentry","category-covid-19-investigational-drugs","category-covid-19"],"_links":{"self":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/42376","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/comments?post=42376"}],"version-history":[{"count":0,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/42376\/revisions"}],"wp:attachment":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/media?parent=42376"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/categories?post=42376"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/tags?post=42376"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}